Search Results 1-10 of 16594 for GLP-1 alternatives

  1. Diabetes drugs and weight loss - Mayo Clinic

    Tirzepatide (Mounjaro) is a similar kind of medicine called a dual-acting GLP-1/GIP agonist. It's also used to control blood sugar and can support weight loss.

  2. Prescription weight-loss drugs - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... FDA's concerns with unapproved GLP-1 drugs used for weight loss. ... https://www.fda.gov/drugs/ ...

  3. Obesity - Diagnosis and treatment - Mayo Clinic

    Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. ... Alternative medicine. Many dietary ...

  4. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. ... options. Accessed Sept. 22, 2022. Wexler DJ ... Glucagon-like peptide ...

  5. Mayo Clinic Minute: Using combined therapy to treat obesity

    Using combined therapy to treat obesity, combining bariatric surgery, also called metabolic surgery, with GLP-1 medications. Learn more.

  6. Using technology to remove barriers to bariatric surgery - Mayo Clinic

    Interest and demand for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ... options to patients. She notes that, unlike many other bariatric surgery programs ...

  7. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... Type 1 diabetes—Should ...

  8. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Type 3 or more letters to display suggested search options ... Glucagon-like peptide 1 receptor agonists (GLP ... alternative explanation to the drug causing new ...

  9. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Type 3 or more letters to display suggested search options. ... Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... It is not safe for one pen to ...

  10. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    ... GLP-1-based obesity medication semaglutide. No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr ...